Briefing
Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY.
In people with colorectal liver metastases from GALAXY, ctDNA was measured with a personalized tumor-informed 16-plex PCR sequencing assay and examined against the survival association of adjuvant chemotherapy.
- Design: Evidence level 2
- Assay: mPCR-NGS
Annals of OncologyPubMed 39293512DOI 10.1016/j.annonc.2024.08.2240